[ad_1] Action Points Two parallel phase II trials of next-generation CFTR correctors showed that both VX-445 and VX-659 improved predicted FEV1 when combined with tezacaftor and ivacaftor in cystic fibrosis patients with …
Read More »CF Triple Therapy Improves Lung Function in Phase II Trials
